Skip to main content

Table 1 Baseline characteristics for both datasets

From: Trends in treatment delays for patients with acute ST-elevation myocardial infarction treated with primary percutaneous coronary intervention

 

HUS-STEMI I

HUS-STEMI II

 
 

n = 194

n = 306

 
 

%

%

p

Mean age, mean (SD) years

64.8 (12.9)

64.3 (14.0)

0.920

Age > 75 years

23.7

26.1

0.542

Male sex

64.9

69.0

0.352

Diabetes

15.5

19.6

0.240

Current smoker

35.6

39.0

0.449

Hypertension

63.4

53.3

0.026

Dyslipidemia

44.8

41.5

0.462

Renal dysfunction

1.5

4.2

0.094

AMI

18.6

10.8

0.014

Stroke

8.8

6.5

0.354

CABG

4.1

5.2

0.573

PCI

9.8

13.4

0.227

ASA

23.2

26.8

0.367

P2Y12 inhibitor

2.1

3.9

0.250

Warfarin

9.3

8.8

0.863

Anterior infarct

46.8

53.6

0.143

Killip class 2--4

12.4

18.0

0.096

Admission at regular hours

41.5

40.8

0.888

  1. Values are percentages with the exception of age.
  2. AMI, acute myocardial infarction; ASA, acetosalicylic acid; CABG, coronary artery bypass graft; PCI, percutaneous coronary intervention.
Back to article page

BMC Cardiovascular Disorders

ISSN: 1471-2261

Contact us